Organization
Altoona Center for Clinical Research, Duncansville, United States
3 abstracts
Abstract
ABATACEPT IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS OF A PHASE II STUDY Org: Altoona Center for Clinical Research, Duncansville, United States, New England Research Associates, LLC, Trumbull, Bristol-Myers Squibb, Princeton, United States, University of Klinische Immunologie, Hamburg, Germany,
Abstract
A SAFETY ANALYSIS OF TOFACITINIB 5 MG TWICE DAILY ADMINISTERED AS MONOTHERAPY OR IN COMBINATION WITH BACKGROUND CONVENTIONAL SYNTHETIC DMARDS IN A PHASE 3 RHEUMATOID ARTHRITIS POPULATION Org: Altoona Center for Clinical Research, Duncansville, United States, Institut de Rhumatologie de Montréal, Montréal, Canada, Sarasota Arthritis Research Center, Sarasota, Pfizer Inc, Collegeville, Pfizer Inc, Groton,
Abstract
ABP 501 BIOSMILAR TO ADALIMUMAB: FINAL SAFETY, IMMUNOGENICITY, AND EFFICACY RESULTS FROM AN OPEN-LABEL EXTENSION STUDY Org: Metroplex Clinical Research Center, Dallas, United States, Instituto de Investigaciόn Hospital, Madrid, Spain, Amgen, Thousand Oaks, United States of America, Abteilung für Nephrologie und Rheumatologie, Göttingen, Germany, Altoona Center for Clinical Research, Duncansville, United States,